Frontiers in Cardiovascular Medicine | Clinical and Translational Cardiovascular Medicine

Original Research

Published on 25 Sep 2025

Elevated novel inflammatory markers in heart failure patients are associated with increased risk of adverse outcomes within one year: insights from a longitudinal study

in Clinical and Translational Cardiovascular Medicine

Zeng Zhao
Chunmei Yuan
Ting Lan
Feng Liu
Guobin Liu
Yuping He
Jing Li
Xingjun Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1683273

780 views

Review

Published on 25 Sep 2025

Regulatory mechanisms of exercise-induced physiological cardiac hypertrophy: progress and prospects

in Clinical and Translational Cardiovascular Medicine

Peng Cheng
Xi Zhang
Yi Si
Qiushi Yin
Lin Chen
Qin Ru
Chong Chu
Hongyue Xiang
Ling Liao
Hang Ran

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1657950

879 views

Review

Published on 23 Sep 2025

Targeting monocyte heterogeneity in aortic aneurysms: immunomodulatory strategies and therapeutic opportunities

in Clinical and Translational Cardiovascular Medicine

Rasit Dinc
Nurittin Ardic

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1670576

789 views

Original Research

Accepted on 22 Sep 2025

The kinetics of CA125 levels as a prognostic marker for in-hospital mortality in patients with acute heart failure: A pilot study

in Clinical and Translational Cardiovascular Medicine

Hai Nguyen Ngoc Dang
Thang Viet Luong
Duy Khanh Tran
Tien Hoang Anh
Duong Hung Tran
Thang Chi Doan
Hung Minh Nguyen
Dung The Bui
Hoa Tran

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1650143

263 views

Original Research

Accepted on 15 Sep 2025

Associations of Angiopoietin-like Protein 7 with Coronary Collateral Circulation and Prognosis of Patients with Severe Coronary Artery Stenosis

in Clinical and Translational Cardiovascular Medicine

Congyi Cheng
Chunlin Wang
Weichun Zhu
Cong Su
Youran Dong
Junlin Teng
Kang Fu
Chungang Zhai
Lei Qiao
Wen-qiang Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1559267

414 views

Correction

Published on 11 Sep 2025

Correction: Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications

in Clinical and Translational Cardiovascular Medicine

Yuqing Niu
Li Wang
Yaoqing Zhang
Yanqiang Zou
Cheng Zhou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1680298

624 views

Review

Accepted on 04 Sep 2025

Innovative Molecular Intervention and Precision Therapy for Atherosclerosis

in Clinical and Translational Cardiovascular Medicine

Zhijie Wang
Wei Peng
Huang Linsheng
Yan Zhang
Jie Yang
Xiaolin Chen
Xiang Liu
Fei-Feng Li
Qiong Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1652933

457 views

Original Research

Published on 03 Sep 2025

A nomogram model based on HALP score and sST2 for predicting 1-year MACE risk after PCI in acute myocardial infarction patients

in Clinical and Translational Cardiovascular Medicine

Chen-Yan Li
Hai-Bo Wu
Ya-Wei Duan
Peng Gao
Hong-Xiao Li
Xue-Chao Wang
Yun-Can Wang
Yan-Qing Wang
Shi-Ru Bai
Yuan Jia

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1641855

669 views

Opinion

Published on 02 Sep 2025

Cognitive alignment in cardiovascular AI: designing predictive models that think with, not just for, clinicians

in Clinical and Translational Cardiovascular Medicine

Jeena Joseph
K. Kartheeban

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1651324

951 views

Review

Published on 01 Sep 2025

ELABELA: a polypeptide with therapeutic potential in cardiovascular diseases

in Clinical and Translational Cardiovascular Medicine

Ping Yan
Cuicui Meng
Shujun Yang
Weiqing Huang
Tong Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1623215

725 views

Review

Published on 01 Sep 2025

Ultrasound-targeted microbubble destruction: a prospective strategy for treating cardiovascular disease

in Clinical and Translational Cardiovascular Medicine

Shuting Yang
Rong Zhang
Huali Zhang
Yongping Lu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1634059

719 views

Brief Research Report

Published on 29 Aug 2025

Lifelong TMAO exposure exerts hypotensive effects in aged spontaneously hypertensive rats

in Clinical and Translational Cardiovascular Medicine

Wojciech Kopacz
Kinga Jaworska
Mateusz Koper
Marcin Ufnal

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1645530

591 views

Original Research

Published on 25 Aug 2025

Serum S100A12 in the clinical diagnosis of sepsis-induced myocardial dysfunction: an integrated bioinformatics and clinical data analysis

in Clinical and Translational Cardiovascular Medicine

Fang Wu
Helin Hong
Ye Tian
Xiaoyan Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1640788

659 views

Review

Published on 20 Aug 2025

The effects of 5-HT on vascular endothelial dysfunction in patients with panic disorder

in Clinical and Translational Cardiovascular Medicine

Yueqi Feng
Xixi Li
Zijia Li
Xinyi He
Yanqing Tang
Wen Tian

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1632070

920 views

Original Research

Published on 15 Aug 2025

Prognostic impact of C-reactive protein in elderly patients with acute heart failure and preserved ejection fraction: the modulating role of carbohydrate antigen 125

in Clinical and Translational Cardiovascular Medicine

Marina García
Pau Llàcer
François Croset
Jorge Campos
Carlos Pérez
Alberto Pérez
Marina Vergara
Paul Cevallos
Esteban Pérez
Cristina Fernández

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1611644

1,325 views

Review

Published on 04 Aug 2025

Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications

in Clinical and Translational Cardiovascular Medicine

Yuqing Niu
Li Wang
Yaoqing Zhang
Yanqiang Zou
Cheng Zhou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1629016

2,047 views
1 citation